Vectorite Biomedical Stock

Vectorite Biomedical Equity Turnover

The Equity Turnover of Vectorite Biomedical (4170.TWO) as of Aug 14, 2026 is 0.13. In the previous year, Equity Turnover was 0.15 — a change of -14.66% (lower).

Equity Turnover

0.13

YoY

-14.66%

Last updated:

Equity Turnover of Vectorite Biomedical is 2026 0.13 . Equity Turnover of Vectorite Biomedical was 2025 0.15 . It decreases by -14.66% lower compared to the previous year.
Access this data via the Eulerpool API

Vectorite Biomedical Stock analysis

What does Vectorite Biomedical do? Vectorite Biomedical is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Vectorite Biomedical stock

Equity Turnover of Vectorite Biomedical is 0.13 in 2026.

Equity Turnover of Vectorite Biomedical changed from 0.15 to 0.13, representing a -14.66% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Equity Turnover Vectorite Biomedical since 2006 – with annual values, charts, and detailed analysis.

Equity turnover measures how efficiently a company uses shareholders' equity to generate revenue. It is a component of the DuPont analysis framework.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Equity Turnover's Vectorite Biomedical with sector peers and the industry average to assess whether it is attractive.

To evaluate Equity Turnover's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Equity Turnover.

Access this data via the Eulerpool API

Profitability — Vectorite Biomedical

All Key Metrics — Vectorite Biomedical